Correlation Between TG Therapeutics and Incyte

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both TG Therapeutics and Incyte at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining TG Therapeutics and Incyte into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between TG Therapeutics and Incyte, you can compare the effects of market volatilities on TG Therapeutics and Incyte and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in TG Therapeutics with a short position of Incyte. Check out your portfolio center. Please also check ongoing floating volatility patterns of TG Therapeutics and Incyte.

Diversification Opportunities for TG Therapeutics and Incyte

0.71
  Correlation Coefficient

Poor diversification

The 3 months correlation between TGTX and Incyte is 0.71. Overlapping area represents the amount of risk that can be diversified away by holding TG Therapeutics and Incyte in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Incyte and TG Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on TG Therapeutics are associated (or correlated) with Incyte. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Incyte has no effect on the direction of TG Therapeutics i.e., TG Therapeutics and Incyte go up and down completely randomly.

Pair Corralation between TG Therapeutics and Incyte

Given the investment horizon of 90 days TG Therapeutics is expected to generate 3.25 times more return on investment than Incyte. However, TG Therapeutics is 3.25 times more volatile than Incyte. It trades about 0.08 of its potential returns per unit of risk. Incyte is currently generating about -0.01 per unit of risk. If you would invest  837.00  in TG Therapeutics on August 27, 2024 and sell it today you would earn a total of  2,670  from holding TG Therapeutics or generate 319.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

TG Therapeutics  vs.  Incyte

 Performance 
       Timeline  
TG Therapeutics 

Risk-Adjusted Performance

14 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in TG Therapeutics are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, TG Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.
Incyte 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Incyte are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak fundamental indicators, Incyte may actually be approaching a critical reversion point that can send shares even higher in December 2024.

TG Therapeutics and Incyte Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with TG Therapeutics and Incyte

The main advantage of trading using opposite TG Therapeutics and Incyte positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if TG Therapeutics position performs unexpectedly, Incyte can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Incyte will offset losses from the drop in Incyte's long position.
The idea behind TG Therapeutics and Incyte pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..

Other Complementary Tools

Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes